YDYusong Ding

Yusong Ding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yusong Ding has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Haiyan Li

    Key Laboratory of Environmental Exposome, Xinjiang Medical University, Urumqi, China

    3 shared publications
  • Tongling Wang

    Department of Public Health, Shihezi University School of Medicine, Shihezi, China

    3 shared publications
  • Baolei Chang

    School of Public Health, Shihezi University, Shihezi, Xinjiang, 832003, China; Key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, Xinjiang Production and Construction Corps, Shihezi, Xinjiang, 832003, China

    2 shared publications
  • Hao Wang

    Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi 832003, Xinjiang, Peoples R China

    2 shared publications
  • Haowei Zhang

    School of Exercise Science, Physical and Health Education, University of Victoria, Victoria, Canada

    2 shared publications
  • Heng Guo

    Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang 832000, China

    2 shared publications

Latest Publications

  • Identification of key biomarkers for ferroptosis in diabetic kidney disease using machine learning and WGCNA

    by Yuxi Liu, Yunfei Huang, Yanyu Su, Lin Wang, Siyi Lv, Yi Fu, Yanling Liu, Baolei Chang, Yusong Ding


  • SIRT1 Regulates Iron Metabolism to Attenuate β-Cell Dedifferentiation by Inhibiting FoxO1 Acetylation

    by Tingting Li, Rulin Ma, Wennv Tang, Yanxia Zheng, Siyi Lv, Yuxi Liu, Lin Wang, Yusong Ding

    Abnormal iron metabolism can cause β-cell dysfunction, and dedifferentiation is the core mechanism of β-cell dysfunction. However, the specific role of abnormal iron metabolism in dedifferentiation remains unclear. Forkhead Box O1 (FoxO1) is a crucial regulator of iron metabolism and dedifferentiation, and its transcriptional activity is regulated by silent information regulator 1 (SIRT1). We aimed to investigate the effects of iron metabolism on dedifferentiation under the action of SIRT1/FoxO1. In vivo, C57BL/6 mice were fed a high-fat diet (HFD). In vitro, MIN6 cells were treated with sodium palmitate (SP). Intraperitoneal glucose tolerance test and insulin tolerance test were used to detect fasting blood glucose in mice. Glucagon, ALDH1A3, Pdx1, and MaFA in the pancreatic tissue were detected by immunofluorescence. Protein levels of SIRT1, FoxO1, Ac-FoxO1, TFRC, DMT1, ferritin, Pdx1, MaFA, and ALDH1A3 in pancreatic tissue and cells were analyzed by Western blotting. Fluorescent probe was used to detect ROS and Fe2+. Insulin levels in cells were detected by enzyme-linked immunosorbent assay. Subsequently, interventions were performed with ferric ammonium citrate (FAC), deferoxamine (DFO), and resveratrol (RSV) to observe the effects of these interventions on iron metabolism and dedifferentiation in MIN6 cells. The results showed that in HFD mice, HOMA-IR was elevated, HOMA-β decreased, glucagon- and ALDH1A3-positive cells increased, and Pdx1- and MaFA-positive cells decreased. In both in vivo and in vitro assays, lipotoxicity resulted in increased expression of Ac-FoxO1, ALDH1A3, TFRC, DMT1, and ferritin and decreased expression of SIRT1, Pdx1, and MaFA. In MIN6 cells, activation of abnormal iron metabolism by FAC resulted in higher ROS levels, decreased Pdx1 and MafA protein expression, increased ALDH1A3 protein expression, and decreased insulin levels. In contrast, inhibition of abnormal iron metabolism with DFO significantly reduced ROS levels and reversed β-cell dedifferentiation. Furthermore, in MIN6 cells, activation of SIRT1 by RSV decreased the expression of Ac-FoxO1, TFRC, DMT1, ferritin, and ALDH1A3; increased Pdx1 and MaFA expression; reduced ROS levels; and elevated insulin levels. SIRT1 inhibits aberrant iron metabolism by inhibiting FoxO1 acetylation levels, reduces ROS levels, and reverses dedifferentiation.


  • Mito-TEMPO Ameliorates Sodium Palmitate Induced Ferroptosis in MIN6 Cells through PINK1/Parkin-Mediated Mitophagy

    by Baolei Chang, Yanyu Su, Tingting Li, Yanxia Zheng, Ruirui Yang, Heng Lu, Hao Wang, Yusong Ding

    Objective Mitochondrial reactive oxygen species (mtROS) could cause damage to pancreatic (3-cells, rendering them susceptible to oxidative damage. Hence, investigating the potential of the mitochondriatargeted antioxidant (Mito-TEMPO) to protect pancreatic (3-cells from ferroptosis by mitigating lipid peroxidation becomes crucial. Methods MIN6 cells were cultured in vitro with 100 mu mol/L sodium palmitate (SP) to simulate diabetes. FerroOrange was utilized for the detection of Fe2+ fluorescence staining, BODIPY581/591C11 for lipid reactive oxygen species, and MitoSox-Red for mtROS. Alterations in mitophagy levels were assessed through the co-localization of lysosomal and mitochondrial fluorescence. Western blotting was employed to quantify protein levels of Acsl4, GPX4, FSP1, FE, PINK1, Parkin, TOMM20, P62, and LC3. Subsequently, interventions were implemented using Mito-TEMPO and Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) to observe changes in ferroptosis and mitophagy within MIN6 cells. Results We found that SP induced a dose-dependent increase in Fe2+ and lipid ROS in MIN6 cells while decreasing the expression levels of GPX4 and FSP1 proteins. Through bioinformatics analysis, it has been uncovered that mitophagy assumes a crucial role within the ferroptosis pathway associated with diabetes. Additionally, SP decreased the expression of mitophagy-related proteins PINK1 and Parkin, leading to mtROS overproduction. Conversely, Mito-TEMPO effectively eliminated mtROS while activating the mitophagy pathways involving PINK1 and Parkin, thereby reducing the occurrence of ferroptosis in MIN6 cells. CCCP also demonstrated efficacy in reducing ferroptosis in MIN6 cells. Conclusion In summary, Mito-TEMPO proved effective in attenuating mtROS production and initiating mitophagy pathways mediated by PINK1 and Parkin in MIN6 cells. Consequently, this decreased iron overload and lipid peroxidation, ultimately safeguarding the cells from ferroptosis.


  • Open Access

    Grape Seed Proanthocyanidins Protect Pancreatic β Cells Against Ferroptosis via the Nrf2 Pathway in Type 2 Diabetes

    by Haiyan Li, Haowei Zhang, Tongling Wang, Liyuan Zhang, Hao Wang, Heng Lu, Ruirui Yang, Yusong Ding

    Pancreatic β cell damage is the primary contributor to type 2 diabetes mellitus (T2DM); however, the underlying mechanism remains nebulous. This study explored the role of ferroptosis in pancreatic β cell damage and the protective effects of grape seed proanthocyanidin extract (GSPE). In T2DM model rats, the blood glucose, water intake, urine volume, HbA1c, and homeostasis model assessment-insulin resistance were significantly increased, while the body weight and the insulin level were significantly decreased, indicating the successful establishment of the T2DM model. MIN6 mouse insulinoma β cells were cultured in high glucose and sodium palmitate conditions to obtain a glycolipid damage model, which was administered with GSPE, ferrostatin-1 (Fer-1), or nuclear factor erythroid 2-related factor 2 (Nrf2) small interfering (si) RNA. GSPE and Fer-1 treatment significantly improved pancreatic β-cell dysfunction and protected against cell death. Both treatments increased the superoxide dismutase and glutathione activity, reduced the malondialdehyde and reactive oxygen species levels, and improved iron metabolism. Furthermore, the treatments reversed the expression of ferroptosis markers cysteine/glutamate transporter (XCT) and glutathione peroxidase 4 (GPX4) caused by glycolipid toxicity. GSPE treatments activated the expression of Nrf2 and related proteins. These effects were reversed when co-transfected with si-Nrf2. GSPE inhibits ferroptosis by activating the Nrf2 signaling pathway, thus reducing β-cell damage and dysfunction in T2DM. Therefore, GSPE is a potential treatment strategy against T2DM. Graphical Abstract


  • Open Access

    Grape Seed Proanthocyanidins Protects Pancreatic β Cells against Ferroptosis via the Nrf2 Pathway in Type 2 Diabetes

    by Yusong Ding, Haiyan Li, Haowei Zhang, Tongling Wang, Liyuan Zhang

    Objective Pancreatic β cell damage is a core cause of type 2 diabetes mellitus (T2DM), but the mechanism has not yet been fully elucidated. This study explored the role of ferroptosis in pancreatic β cell damage and the protective effects of grape seed proanthocyanidins (GSPE). Methods T2DM rat model was established. In T2DM rats, the blood glucose, water intake, urine volume, HbA1c, and homeostasis model assessment-insulin resistance were significantly increased, while the body weight and the insulin level were significantly decreased, indicating the successful establishment of T2DM model. MIN6 mouse insulinoma β cells were cultured in high glucose and sodium palmitate conditions to obtain glycolipid damage model, which was administrated with GSPE, Ferrostatin-1 (Fer-1) or nuclear factor erythroid 2-related factor 2 (Nrf2) small interfering (si) RNA. Results GSPE and Fer-1 treatment significantly improved pancreatic β cell dysfunction and protected against cell death. Both treatments increased the superoxide dismutase and glutathione activity, reduced the malondialdehyde and reactive oxygen species levels, and improved the iron metabolism. Furthermore, both treatments reversed the expression of ferroptosis markers cysteine/glutamate transporter (XCT) and glutathione peroxidase 4 (GPX4) caused by glycolipid toxicity. Moreover, GSPE treatments activated the expression of Nrf2 and related proteins. These effects were reversed when co-transfected with si-Nrf2. Conclusion These results demonstrate that GSPE inhibits ferroptosis by activating the Nrf2 signaling pathway, thus reducing β cell damage and dysfunction in T2DM. GSPE could be a potential agent for T2DM treatment.

  • Open Access

    Protective effects of grape seed proanthocyanidins on podocytes against injury induced by glucolipotoxicity

    by Haiyan Li, Tongling Wang, Dandan Liu, Yusong Ding, Jinbao Liu

    Diabetic nephropathy (DN) is the most common cause of end-stage renal failure, oxidative damage and iron metabolism disorder are related to DN progression, but the exact pathogenesis remains unclear. Grape seed proanthocyanidins extract (GSPE) are one of the most widely distributed polyphenols with antioxidant properties. Here, we evaluate the mechanism by which GSPE alleviates podocyte damage induced by high glucose and palmitic acid (HG/PA). Podocytes were cultured in groups in normal environment; these were based on whether HG/PA and ML385 were present and the concentrations GSPE 10 mg/L, GSPE 25 mg/L, and GSPE 50 mg/. The flow cytometer, immunofluorescence staining, western blot, quantitative real time-PCR (qRT-PCR), kit methodand, and fluorescence microscope were used, respectively. After HG/PA intervention, the podocyte morphology was destroyed, the survival rate was reduced, the cell apoptosis was increased, and the fluorescence intensity of ROS detection was increased, iron metabolism was disordered. After adding ML385, increased oxidative damage to podocyte, nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream protein and mRNA expression levels were significantly reduced. However, the application of different concentrations of GSPE can reverse these situations. Our findings indicate that GSPE regulates intracellular iron metabolism disorders and reduces oxidative damage of podocytes possibly through the activation of the Nrf2 signaling pathway.

  • Nanosized Titanium Dioxide Induced Apoptosis and Abnormal Expression of Blood-Testis Barrier Junction Proteins Through JNK Signaling Pathway in TM4 Cells

    by Yaxin Deng, Xiaojia Meng, Chunmei Ling, Tianjiao Lu, Hongmei Chang, Li Li, Yaqian Yang, Guanling Song, Yusong Ding

    Nanosized titanium dioxide (nano-TiO2) has been widely used in consumer products. It can cross the blood-testis barrier (BTB), and it has adverse effects on the male reproductive system. However, the specific mechanism has not been fully elucidated. The purpose of this study was to understand the role of the JNK signaling pathway in the apoptosis and abnormal expression of BTB junction proteins induced by nano-TiO2 in TM4 cells. After different concentration of nano-TiO2 treatments, the cell viability, apoptosis, mitochondrial membrane potential (Δψm), BTB junction proteins (Claudin-11, ZO-1, β-catenin), apoptosis-related proteins (Bax, Bcl-2, cleaved caspase-9, cleaved caspase-3), and phosphorylated (p)-JNK protein were examined. The results showed that cell viability, apoptosis rates, Δψm, and apoptosis-related protein levels changed in a concentration-dependent manner. Cell viability decreased significantly from 100 μg/mL nano-TiO2 group. Apoptosis rates increased significantly from 150 μg/mL nano-TiO2 group, and Δψm decreased significantly from 150 μg/mL nano-TiO2 group. The protein levels of Bax, cleaved caspase-9, and cleaved caspase-3 increased significantly from 150 μg/mL nano-TiO2 group, and the protein level of Bcl-2 decreased significantly from 100 μg/mL nano-TiO2 group. The protein level of p-JNK increased significantly from 100 μg/mL nano-TiO2 group. Abnormal expression of ZO-1 and β-catenin started from 150 μg/mL nano-TiO2 group, and abnormal expression of Claudin-11 started from 100 μg/mL nano-TiO2 group. Cells were treated with JNK inhibitor SP100625 to determine whether the changes of the above indicators in the concentration of 150 μg/mL nano-TiO2 group can be reversed. We found that SP100625 at 20 μM significantly reversed these effects. These results highlighted that nano-TiO2 could activate the JNK signaling pathway to induce mitochondria-mediated apoptosis and abnormal expression of BTB junction proteins in TM4 cells.


  • Open Access

    Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio

    by Yu-Song Ding, Shu-Xia Guo, Ru-Lin Ma, Shu-Gang Li, Heng Guo, Jing-Yu Zhang, Mei Zhang, Jia-Ming Liu, Jia He, Yi-Zhong Yan, et al.

    This study aimed at determining whether the adiponectin to HOMA‐IR (A/H) ratio is associated with MetS and MetS components and comparing the diagnostic efficacy of adiponectin, HOMA‐IR, and the A/H ratio in healthy, middle‐aged participants. MetS was assessed in 1628 Kazakh participants (men, 768; women, 860). The associations between adiponectin, HOMA‐IR, and the A/H ratio with the components of MetS and MetS were examined using logistic regression analysis and receiver operating characteristic (ROC) curves. Our results show that A/H ratio may be a better diagnostic marker for MetS than either HOMA‐IR or adiponectin alone, and it may serve as an important biomarker to determine an increased risk for MetS in healthy middle‐aged population.